<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "JATS-journalpublishing1-4.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.4" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">wjcd</journal-id>
      <journal-title-group>
        <journal-title>World Journal of Cardiovascular Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2164-5337</issn>
      <issn pub-type="ppub">2164-5329</issn>
      <publisher>
        <publisher-name>Scientific Research Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.4236/wjcd.2026.164023</article-id>
      <article-id pub-id-type="publisher-id">wjcd-150735</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
        <subj-group>
          <subject>Medicine</subject>
          <subject>Healthcare</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Prevalence of Hypertension and Its Clinical and Therapeutic Aspects among Young Adults (Aged 18 - 40) at Owendo University Hospital Center (Gabon): A Descriptive Cross-Sectional Study</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Konde</surname>
            <given-names>Christelle P. Akagha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Obiang</surname>
            <given-names>Francis Ndoume</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mikoumou</surname>
            <given-names>Moupinda</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Kinga</surname>
            <given-names>Armel</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Alakoua</surname>
            <given-names>Lidvine Cajole Ndjibah</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Mpori</surname>
            <given-names>Jamila Myrtille</given-names>
          </name>
          <xref ref-type="aff" rid="aff4">4</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Yekini</surname>
            <given-names>Fadylath Carole</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bengou</surname>
            <given-names>Wilfrid Gérald Tessa</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sima</surname>
            <given-names>Jean Joseph Ekwa</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Allognon</surname>
            <given-names>Mahutondji Christian</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bivigou</surname>
            <given-names>Elsa Ayo</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">3</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Owendo University Hospital Center, Owendo, Gabon </aff>
      <aff id="aff2"><label>2</label> Professor Daniel Gahouma Institute of Infectious Diseases, Owendo, Gabon </aff>
      <aff id="aff3"><label>3</label> Libreville University Hospital Center, Libreville, Gabon </aff>
      <aff id="aff4"><label>4</label> Mère-Enfant Fondation Jeanne Ebori University Hospital Center, Libreville, Gabon </aff>
      <author-notes>
        <fn fn-type="conflict" id="fn-conflict">
          <p>The authors declare no conflicts of interest.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>01</day>
        <month>04</month>
        <year>2026</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>04</month>
        <year>2026</year>
      </pub-date>
      <volume>16</volume>
      <issue>04</issue>
      <fpage>227</fpage>
      <lpage>237</lpage>
      <history>
        <date date-type="received">
          <day>
          </day>
          <month>
          </month>
          <year>
          </year>
        </date>
        <date date-type="accepted">
          <day>
          </day>
          <month>
          </month>
          <year>
          </year>
        </date>
        <date date-type="published">
          <day>01</day>
          <month>04</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2026 by the authors and Scientific Research Publishing Inc.</copyright-statement>
        <copyright-year>2026</copyright-year>
        <license license-type="open-access">
          <license-p> This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link> ). </license-p>
        </license>
      </permissions>
      <self-uri content-type="doi" xlink:href="https://doi.org/10.4236/wjcd.2026.164023">https://doi.org/10.4236/wjcd.2026.164023</self-uri>
      <abstract>
        <p><bold>Introduction</bold>: Hypertension is a major public health issue given its serious complications. Studies conducted in school settings in Gabon have revealed a high prevalence of hypertension among young people (19.4% to 28.0%), but hospital-based data remain scarce. The objective of this study was to determine the hospital prevalence of hypertension in young adults and to describe its clinical and therapeutic aspects. <bold>Methods</bold>: This was a descriptive cross-sectional study with retrospective data collection from the medical records of hypertensive patients aged 18 to 40 years who attended outpatient cardiology consultations at the Owendo University Hospital Center from February 11 to December 31, 2021. Sociodemographic, clinical, paraclinical and therapeutic parameters were collected. Pregnancy-related hypertensive disorders were distinguished from chronic hypertension in the interpretation of results. Hypertension was defined according to the European Society of Cardiology criteria. <bold>Results</bold>: Among the 534 patients seen, 51 met the selection criteria, corresponding to a hospital frequency of HBP in young adults of 9.6%. The median age was 35 years [18 - 39 years], with a sex ratio of 0.34. Obesity was present in 21.6% of patients. Hypertension was systolic-diastolic in 68.2% of cases and grade 3 in 76.6% of patients. A family history of hypertension was found in 17.6% of cases. In women, hypertension occurred in the context of current preeclampsia (52.6%) or previous preeclampsia (13.2%). In men, hypertension revealed chronic kidney disease (4/13 cases) or heart failure (3/13 cases). Dual antihypertensive therapy was prescribed in 51.8% of hypertensive patients outside pregnancy. <bold>Conclusion</bold>: Hypertension is common among young adults attending outpatient cardiology consultations at the Owendo University Hospital Center. A context of current or previous preeclampsia predominates in women. In men, complications are frequent. Early screening and appropriate management of HBP are essential. Etiological investigation should be performed.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated" xml:lang="en">
        <kwd>Hypertension</kwd>
        <kwd>Young Adult</kwd>
        <kwd>Outpatient Consultation</kwd>
        <kwd>Preeclampsia</kwd>
        <kwd>Owendo</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
    </sec>
    <sec id="sec2">
      <title>1. Introduction</title>
      <p>Hypertension is a major public health problem due to its serious complications [<xref ref-type="bibr" rid="B1">1</xref>]. Often perceived as a condition associated with aging, its incidence among adults aged 40 years and younger is increasing, particularly in Sub-Saharan Africa.</p>
      <p>In South Africa, the prevalence among individuals aged 24 - 40 years reaches 24.0% [<xref ref-type="bibr" rid="B2">2</xref>].</p>
      <p>In Gabon, school-based studies have revealed a high frequency of hypertension in young people (19.4% to 28.0%) [<xref ref-type="bibr" rid="B3">3</xref>][<xref ref-type="bibr" rid="B4">4</xref>]. In the urban hospital, it was estimated at 14.7% among patients who consulted at the Libreville University Hospital Center [<xref ref-type="bibr" rid="B5">5</xref>]. </p>
      <p>The main concern lies in the early severity of this condition among melanoderm individuals and the lack of data on the clinical profile of young adults in peri-urban settings. Hypertension in young people is often associated with poor awareness of the disease (only 16.8% reported good levels of awareness in South Africa) and with a high cardiovascular risk from the time of diagnosis [<xref ref-type="bibr" rid="B2">2</xref>][<xref ref-type="bibr" rid="B5">5</xref>].</p>
      <p>The objective of this study was to determine the hospital frequency of hypertension among young adults attending cardiology consultations at the Owendo University Hospital Center and to describe its clinical and therapeutic aspects.</p>
    </sec>
    <sec id="sec3">
      <title>2. Methods</title>
      <sec id="sec3dot1">
        <title>2.1. Study Design</title>
        <p>This was a descriptive cross-sectional observational study with retrospective data collection.</p>
      </sec>
      <sec id="sec3dot2">
        <title>2.2. Setting</title>
        <p>The study was conducted at the Owendo University Hospital Center. This is a level III hospital and a reference trauma center that also includes a gynaecology and obstetrics department. An official cardiology service began operating in February 2021 with the assignment of a cardiologist to the facility. The first data from outpatient cardiology consultations were used for this study.</p>
      </sec>
      <sec id="sec3dot3">
        <title>2.3. Study Population</title>
        <p>The data source consisted of the medical records of patients who attended consultations between February 11 and December 31, 2021.</p>
      </sec>
      <sec id="sec3dot4">
        <title>2.4. Selection Criteria</title>
        <p>The selected medical records met the following criteria:</p>
        <p>records of patients with confirmed hypertension according to the recommendations of the European Society of Cardiology (blood pressure ≥ 140/90 mmHg or patients receiving antihypertensive treatment) [<xref ref-type="bibr" rid="B6">6</xref>];records containing at least the following information: age, sex, and blood pressure.</p>
      </sec>
      <sec id="sec3dot5">
        <title>2.5. Exclusion Criterion</title>
        <p>The absence of the minimum required information in the medical record constituted the exclusion criterion.</p>
      </sec>
      <sec id="sec3dot6">
        <title>2.6. Study Variables</title>
        <p>The variables extracted from the records included:</p>
        <p>Sociodemographic data: age and sex.Clinical data: reason for consultation, personal or family history of hypertension or cardiovascular disease, history of hypertensive disorders of pregnancy (past or current), cardiovascular risk factors, weight, height, body mass index calculation, systolic and diastolic blood pressure, and heart rate.Outcome variables: cardiac, renal, neurological, or ophthalmological complications of hypertension.Therapeutic variables: prescribed therapeutic categories, number of medications, treatment compliance, and blood pressure control for patients who had more than one consultation.</p>
        <p>Pregnancy-related hypertensive disorders have been distinguished from chronic hypertension in the interpretation of results. However, global descriptive analyzes include all patients in order to reflect the clinical reality of recruitment.</p>
      </sec>
      <sec id="sec3dot7">
        <title>2.7. Operational Definitions</title>
        <p>An age of 40 years or younger defined a young adult.</p>
        <p>Blood pressure values were classified according to the 2018 classification of the European Society of Cardiology [<xref ref-type="bibr" rid="B6">6</xref>].</p>
        <p>Heart rate was considered elevated when it was greater than or equal to 80 beats per minute.</p>
        <p>The Quetelet Index classification was used to define weight status based on the body mass index. </p>
        <p>Therapeutic compliance was self-reported. Patients whose records mentioned “treatment interruption,” “non-compliance,” or “treatment not taken” were considered non-compliant. Blood pressure control was defined as blood pressure lower than 140/90 mmHg during consultation. It was assessed in patients who had at least one follow-up visit. The assessment was based on blood pressure values measured at the last visit. The follow-up interval was not standardized due to the retrospective nature of study.</p>
      </sec>
      <sec id="sec3dot8">
        <title>2.8. Sample Size</title>
        <p>The number of included records corresponded to all patients who met the selection criteria during the study period.</p>
      </sec>
      <sec id="sec3dot9">
        <title>2.9. Data Collection, Processing, and Analysis</title>
        <p>Data were collected using Microsoft Excel 365 and analyzed with Epi Info 7.</p>
        <p>Quantitative variables were expressed as averages with standard deviation when the distribution was normal, and as medians with extremes when the distribution was non-normal. Qualitative variables were expressed as frequencies and percentages.</p>
        <p>The hospital frequency of hypertension among young adults was calculated from the total number of patients who consulted during the study period. The proportion of young hypertensive patients was calculated from the total number of hypertensive patients during the study period.</p>
        <p>Records containing the required data for the study but with missing variables were excluded from the analysis for those specific variables. The analyses were carried out using dominators corresponding to available data for each parameter. The analyzed sample sizes were specified for each parameter when data were missing.</p>
      </sec>
      <sec id="sec3dot10">
        <title>2.10. Ethical Considerations</title>
        <p>Prior authorization from the head of the department and from the hospital administration was obtained to conduct this study. The data were anonymized before analysis. Due to the retrospective nature of the study, individual consent was not required.</p>
      </sec>
    </sec>
    <sec id="sec4">
      <title>3. Results</title>
      <p>During the study period, 534 medical records covering all pathologies were collected. Among them, 51 met the selection criteria, corresponding to a hospital frequency of 9.6% for hypertension in young adults. These young patients represented 12% of all hypertensive patients. <xref ref-type="fig" rid="fig1">Figure 1</xref> presents the flow diagram of patient records included in the study.</p>
      <sec id="sec4dot1">
        <title>3.1. Sociodemographic Data</title>
        <p>The median age was 35 years, with extremes ranging from 18 to 39 years. Participants were 31 years or older in 76.5% of cases. The sex ratio was 0.34 (<bold>Table 1</bold>).</p>
        <fig id="fig1">
          <label>Figure 1</label>
          <graphic xlink:href="https://html.scirp.org/file/1911753-rId13.jpeg?20260414030405" />
        </fig>
        <p>Figure 1. Flowchart of records from the study on hypertension in young subjects, Owendo 2021.</p>
        <p>Table 1. General population data.</p>
        <table-wrap id="tbl1">
          <label>Table 1</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Variables</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Age</bold>
                  (years): median [extremes]
                </td>
                <td>35 [18, 39]</td>
              </tr>
              <tr>
                <td>Age groups (years): n (%)</td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- 18 - 24</td>
                <td>03 (05.9)</td>
              </tr>
              <tr>
                <td>- 25 - 30</td>
                <td>09 (17.6)</td>
              </tr>
              <tr>
                <td>- 31 - 35</td>
                <td>18 (35.3)</td>
              </tr>
              <tr>
                <td>- 36 - 40</td>
                <td>21 (41.2)</td>
              </tr>
              <tr>
                <td>
                  <bold>Sex</bold>
                  <bold>:</bold>
                  n (%)
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- Male</td>
                <td>13 (25.5)</td>
              </tr>
              <tr>
                <td>- Female</td>
                <td>38 (74.5)</td>
              </tr>
              <tr>
                <td> Hypertension + preeclampsia</td>
                <td>19 (39.2)</td>
              </tr>
              <tr>
                <td> Hypertension without preeclampsia</td>
                <td>18 (35.3)</td>
              </tr>
              <tr>
                <td>
                  <bold>Background</bold>
                  <bold>information</bold>
                  : n (%)
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- Hereditary hypertension</td>
                <td>09/51 (17.6)</td>
              </tr>
              <tr>
                <td>- Previous preeclampsia</td>
                <td>05/38 (13.2)</td>
              </tr>
              <tr>
                <td>- Current preeclampsia</td>
                <td>20/38 (52.6)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
      </sec>
      <sec id="sec4dot2">
        <title>3.2. Clinical Data</title>
        <p><bold>Table 2</bold> shows the clinical and evolutionary data of the patients in the study. Most consultations for hypertension in young adults were related to follow-up of chronic hypertension or referral by a general practitioner or gynaecologist. Referral by a gynaecologist was related to hypertensive disorders of pregnancy in 37.5% of cases.</p>
        <p>On the one hand, hypertension was chronic in 31 patients (60.8%), including13 men (41.9%) and 18 women (58.1%). A history of preeclampsia was noted in five of these women (27.8%). On the other hand, hypertension was secondary to current preeclampsia in 20 women (39.2%).</p>
        <p>Table 2. Clinical data and target organ damage.</p>
        <table-wrap id="tbl2">
          <label>Table 2</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Variables</bold>
                </td>
                <td>
                  <bold>n = 51</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Reasons for consultation: n (%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>-</bold>
                  <bold>Patients with a history of hypertension</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Hypertension monitoring</td>
                <td>15 (29.4)</td>
              </tr>
              <tr>
                <td>Superimposed preeclampsia</td>
                <td>01 (02.0)</td>
              </tr>
              <tr>
                <td>Side effect of an antihypertensive drug</td>
                <td>01 (02.0)</td>
              </tr>
              <tr>
                <td>
                  <bold>-</bold>
                  <bold>Patients with newly diagnose</bold>
                  <bold>d hyperten</bold>
                  <bold>s</bold>
                  <bold>ion</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>Palpitations</td>
                <td>03 (05.8)</td>
              </tr>
              <tr>
                <td>Patient consulting at the complication stage</td>
                <td>06 (11.8)</td>
              </tr>
              <tr>
                <td>Referred by a general practitioner for hypertension monitoring</td>
                <td>06 (11.8)</td>
              </tr>
              <tr>
                <td>Referred by gynaecologist for follow-up after an SPE or eclampsia</td>
                <td>19 (37.2)</td>
              </tr>
              <tr>
                <td>
                  <bold>Weight Status:</bold>
                  n (%)
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- Normal</td>
                <td>08 (15.6)</td>
              </tr>
              <tr>
                <td>- Overweight</td>
                <td>08(15.6)</td>
              </tr>
              <tr>
                <td>- Obesity</td>
                <td>15 (29.4)</td>
              </tr>
              <tr>
                <td>- N/a</td>
                <td>20 (39.2)</td>
              </tr>
              <tr>
                <td>
                  <bold>Heart rate</bold>
                  : n (%)
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- &lt;80 bpm</td>
                <td>19 (37.3)</td>
              </tr>
              <tr>
                <td>- ≥80 bpm</td>
                <td>32 (62.7)</td>
              </tr>
              <tr>
                <td>
                  <bold>Blood pressure level</bold>
                  (mmHg): n (%)
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- Normal</td>
                <td>12 (23.5)</td>
              </tr>
              <tr>
                <td>- Grade I hypertension</td>
                <td>06 (11.7)</td>
              </tr>
              <tr>
                <td>- Grade II hypertension</td>
                <td>11 (21.5)</td>
              </tr>
              <tr>
                <td>- Grade III</td>
                <td>22 (43.1)</td>
              </tr>
              <tr>
                <td>
                  <bold>Hypertension types:</bold>
                  n (%)
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- Systolic</td>
                <td>00 (00.0)</td>
              </tr>
              <tr>
                <td>- Diastolic</td>
                <td>04 (07.8)</td>
              </tr>
              <tr>
                <td>- Systolic-diastolic</td>
                <td>35 (68.6)</td>
              </tr>
              <tr>
                <td>
                  <bold>Damage to target organs by hypertension</bold>
                  : n (%)
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- Heart failure</td>
                <td>03 (5.9)</td>
              </tr>
              <tr>
                <td>- Chronic kidney disease</td>
                <td>01 (2.0)</td>
              </tr>
              <tr>
                <td>- Heart failure + chronic kidney disease</td>
                <td>02 (3.9)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Bpm: beats per minute; N/a: not available; SRE: Severe Preeclampsia.</p>
        <p>A family history of hypertension was found in 17.6% of cases. BMI, available for 31 patients, averaged 31.0 ± 8.3 kg/m<sup>2</sup>, with overweight or obesity present in 68.6% of cases. </p>
        <p>Other cardiovascular risk factors included:</p>
        <p>elevated heart rate (62.7%)diabetes (2%)stress (2%)</p>
        <p>The average heart rate was 89.7 ± 14.1 beats per minute. </p>
        <p>Across the entire sample and in all patients outside the context of current preeclampsia, the average systolic blood pressure was 154.7 ± 20.3 mmHg, and the average diastolic blood pressure was 105.7 ± 20.4 mmHg. At the first consultation, 64.6% of patients were in grade II or III hypertension. Systolic-diastolic hypertension was observed in 68.6% of cases.</p>
        <p>In women with current preeclampsia, the average systolic blood pressure was 147.7 ± 31.7 mmHg and the mean diastolic blood pressure was 100.2 ± 20.2 mmHg. Blood pressure at the first consultation was grade II or III in 55.0% of cases.</p>
      </sec>
      <sec id="sec4dot3">
        <title>3.3. Evolutive Data</title>
        <p>A complication of chronic hypertension was identified in six patients (11.8%), all of whom were men. These complications—cardiac (5.9%), renal (2.0%), or both (3.9%)—represented the mode of discovery of hypertension in these patients (table II). Among women, the recorded complications were related to hypertensive disorders of pregnancy. These included:</p>
        <p>eclampsiaHELLP syndromeretroplacental hematomadisseminated intravascular coagulation</p>
        <p>Each condition accounted for one case (2.0%).</p>
      </sec>
      <sec id="sec4dot4">
        <title>3.4. Therapeutic Data</title>
        <p>Treatment consisted of at least dual antihypertensive therapy in 58.9% of cases.</p>
        <p>Calcium channel blockers were the most frequently prescribed therapeutic category, either as monotherapy or in combination. Of the 51 patients, 27 (52.9%) attended follow-up consultations. Blood pressure control was achieved in 37% of these patients, most of whom were women (80%). Therapeutic compliance, documented in 21 medical records, was 31.8% (<bold>Table 3</bold>).</p>
        <p>Table 3. Prescribed treatment, therapeutic compliance and blood pressure monitoring.</p>
        <table-wrap id="tbl3">
          <label>Table 3</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Variables</bold>
                </td>
                <td>
                  <bold>n</bold>
                  <bold>=</bold>
                  <bold>51*</bold>
                </td>
              </tr>
              <tr>
                <td>
                  <bold>Type</bold>
                  <bold>of</bold>
                  <bold>treatment</bold>
                  <bold>:</bold>
                  <bold>n</bold>
                  <bold>(%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- HDM solely</td>
                <td>06 (11.8)</td>
              </tr>
              <tr>
                <td>- Monotherapy</td>
                <td>15 (29.4)</td>
              </tr>
              <tr>
                <td>- Dual therapy</td>
                <td>14 (27.5)</td>
              </tr>
              <tr>
                <td>- Triple therapy</td>
                <td>15 (29.4)</td>
              </tr>
              <tr>
                <td>- Quadruple therapy</td>
                <td>01 (02.0)</td>
              </tr>
              <tr>
                <td>
                  <bold>Prescribed</bold>
                  <bold>therapeutic</bold>
                  <bold>categories</bold>
                  <bold>:</bold>
                  <bold>n</bold>
                  <bold>(%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- ACE inhibitor</td>
                <td>11 (21.6)</td>
              </tr>
              <tr>
                <td>- ARA II</td>
                <td>09 (17.6)</td>
              </tr>
              <tr>
                <td>- Calcium antagonist</td>
                <td>28 (54.9)</td>
              </tr>
              <tr>
                <td>- Diuretics</td>
                <td>17 (33.3)</td>
              </tr>
              <tr>
                <td>- Beta blockers</td>
                <td>10 (19.6)</td>
              </tr>
              <tr>
                <td>- Central antihypertensive</td>
                <td>11 (21.6)</td>
              </tr>
              <tr>
                <td>
                  <bold>Prescribed</bold>
                  <bold>therapeutic</bold>
                  <bold>combinations</bold>
                  <bold>:</bold>
                  <bold>n</bold>
                  <bold>(%)</bold>
                </td>
                <td>
                </td>
              </tr>
              <tr>
                <td>- ACE inhibitor or ARA II + calcium antagonist</td>
                <td>07 (13.7)</td>
              </tr>
              <tr>
                <td>- Calcium antagonist + diuretic</td>
                <td>04 (07.8)</td>
              </tr>
              <tr>
                <td>- Other dual therapies</td>
                <td>03 (05.9)</td>
              </tr>
              <tr>
                <td>- ACE inhibitor or ARA II +diuretics + calcium antagonists</td>
                <td>08 (15.7)</td>
              </tr>
              <tr>
                <td>- ACE inhibitor or ARA II +diuretics + beta blockers</td>
                <td>04 (07.8)</td>
              </tr>
              <tr>
                <td>- Central + calcium antagonist + beta blocker</td>
                <td>03 (05.9)</td>
              </tr>
              <tr>
                <td>
                  <bold>Therapeutic</bold>
                  <bold>compliance</bold>
                  <bold>:</bold>
                  <bold>n</bold>
                  <bold>(%)</bold>
                </td>
                <td>08/21 (38.1)</td>
              </tr>
              <tr>
                <td>
                  <bold>Follow-up</bold>
                  <bold>consultation:</bold>
                  <bold>n</bold>
                  <bold>(%)</bold>
                </td>
                <td>27/51 (52.9)</td>
              </tr>
              <tr>
                <td>
                  <bold>Blood</bold>
                  <bold>pressure</bold>
                  <bold>control</bold>
                  <bold>:</bold>
                  <bold>n</bold>
                  <bold>(%)</bold>
                </td>
                <td>10/27 (37.0)</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>ARA II: angiotensin II receptor antagonist; ACE: angiotensin-converting enzyme inhibitor; HDM: Hygiene and dietary measures. *Unless specified figure is given in the denominator.</p>
      </sec>
    </sec>
    <sec id="sec5">
      <title>4. Discussion</title>
      <sec id="sec5dot1">
        <title>4.1. Achievement of Study Objectives</title>
        <p>The objective of this study was to determine the hospital prevalence of hypertension in young adults attending cardiology consultations at the Owendo University Hospital Center and to describe its clinical and therapeutic aspects.</p>
        <p>The study showed a hospital prevalence of 9.6%, a median age of 35 years [18 - 39], and a female predominance. Overweight and obesity were frequent, and a history of preeclampsia was commonly identified. From a therapeutic perspective, most patients received at least dual therapy in the majority of cases, although the blood pressure control rate remained low.</p>
      </sec>
      <sec id="sec5dot2">
        <title>4.2. Discussion of Results and Comparison with the Literature</title>
        <p>4.2.1. Demographic Profile</p>
        <p>The female predominance observed at the Owendo University Hospital Center contrasts with some global data in which hypertension among young adults is often more common in men [<xref ref-type="bibr" rid="B7">7</xref>]-[<xref ref-type="bibr" rid="B9">9</xref>]. However, this finding is consistent with the study by Mtintsilana in South Africa, which also reported a high prevalence among women [<xref ref-type="bibr" rid="B2">2</xref>]. It also confirms the findings of Ndoume at the Libreville University Hospital Center [<xref ref-type="bibr" rid="B2">2</xref>].</p>
        <p>This female predominance may also be explained by the close relationship with maternal health, as this hospital has a large obstetrics and gynaecology activity.</p>
        <p>4.2.2. Overweight and Obesity </p>
        <p>The high prevalence of overweight and obesity in this study is consistent with the findings of Ayo et al, who studied a population of high school students and demonstrated the impact of semi-urban lifestyle changes in Owendo [<xref ref-type="bibr" rid="B3">3</xref>].</p>
        <p>4.2.3. Clinical Severity</p>
        <p>The high proportion of patients presenting initially with grade 3 hypertension is consistent with the severe hypertension found in other African studies [<xref ref-type="bibr" rid="B10">10</xref>][<xref ref-type="bibr" rid="B11">11</xref>]. A proportion of patients had already developed complications. These findings corroborate those of Ndoume in Libreville and confirm that hypertension in melanoderm populations of Sub-Saharan Africa tends to be particularly aggressive and early in onset [<xref ref-type="bibr" rid="B5">5</xref>][<xref ref-type="bibr" rid="B11">11</xref>].</p>
        <p>The severity of blood pressure levels at diagnosis contrasts with the predominance of grade 1 hypertension reported in high-income countries. It suggests that hypertension may have remained undetected for several years. The low level of awareness about hypertension (only 16.8% good knowledge scores in the South African study) could explain this delay in consultation [<xref ref-type="bibr" rid="B2">2</xref>][<xref ref-type="bibr" rid="B10">10</xref>].</p>
        <p>4.2.4. Hypertensive Disorders of Pregnancy</p>
        <p>More than half of the women had a past or recent history of preeclampsia. It has been demonstrated that preeclampsia increases the risk of chronic hypertension three-to four-fold. Mianroh, Voskamp, McDonald and other authors have shown that 26.0% to 60.0% of patients remained hypertensive after preeclampsia [<xref ref-type="bibr" rid="B12">12</xref>]-[<xref ref-type="bibr" rid="B16">16</xref>].</p>
        <p>The transition from preeclampsia to permanent hypertension represents a missed opportunity for prevention. For these women, pregnancy appears to act as an early indicator of vascular vulnerability, requiring long-term cardiological follow-up that is often neglected after childbirth.</p>
        <p>Thus, this study highlights maternity care as a key entry point for hypertension screening.</p>
        <p>4.2.5. Blood Pressure Control</p>
        <p>This study showed a low rate of blood pressure control among young adults despite frequent prescription of combination therapy, suggesting problems of treatment compliance, which are common in this population [<xref ref-type="bibr" rid="B1">1</xref>][<xref ref-type="bibr" rid="B10">10</xref>].</p>
        <p>The recommendations of the European Society of Cardiology advocate the use of fixed-dose combinations to improve compliance [<xref ref-type="bibr" rid="B6">6</xref>].</p>
        <p>Clinical inertia and the cost of medications may also represent major barriers to effective blood pressure control [<xref ref-type="bibr" rid="B5">5</xref>].</p>
        <p>The assessment of blood pressure control should be interpreted with caution due to the lack of standardization in follow-up and the variable number of visits per patient.</p>
        <p>4.2.6. Target Organ Damage</p>
        <p>Complications of hypertension were mainly observed in men and were sometimes the presenting symptom. This suggests later management in this group, possibly related to late screening. </p>
        <p>These results highlight the need for early screening strategies and appropriate follow-up in young people to prevent long-term cardiovascular complications.</p>
      </sec>
      <sec id="sec5dot3">
        <title>4.3. Strengths and Limitations</title>
        <p>The main strength of this study is that it provides the first data on hypertension among young adults in a semi-urban center primarily dedicated to trauma care but also including obstetrics and gynaecology services.</p>
        <p>It confirms the findings of a previous study conducted in Libreville regarding the severity of blood pressure levels at diagnosis. It also describes the types of treatment prescribed, particularly the frequent use of combination therapy.</p>
        <p>Furthermore, it highlighted a predisposing factor for chronic hypertension—preeclampsia—indicating the need for stronger screening and monitoring strategies. </p>
        <p>However, the single-center nature of the study limits the generalization of the results. Also, the presence of missing data for some variables, due to the retrospective collection, may limit the accuracy of some estimates.</p>
      </sec>
    </sec>
    <sec id="sec6">
      <title>5. Conclusion</title>
      <p>Hypertension in young adults at the Owendo University Hospital Center is frequent and often severe. A female predominance is observed, partly related to hypertensive disorders of pregnancy. Complications were mainly found in men. Blood pressure control was insufficient despite the frequent use of polypharmacy. Overweight, obesity and preeclampsia are common, although this study does not establish a causal link. To integrate systematic screening in young people, to establish a follow-up program for women who have experienced hypertensive disorder during pregnancy and to strengthen therapeutic education are essential to prevent irreversible cardiovascular complications in young adults.</p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <citation-alternatives>
          <mixed-citation publication-type="report">World Health Organization (2025) Global Report on Hypertension 2025 High Stakes—Turning Evidence into Action. World Health Organization.</mixed-citation>
          <element-citation publication-type="report">
            <year>2025</year>
            <article-title>Global Report on Hypertension 2025 High Stakes—Turning Evidence into Action</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Mtintsilana, A., Mapanga, W., Craig, A., Dlamini, S.N. and Norris, S.A. (2025) Self-Reported Hypertension Prevalence, Risk Factors, and Knowledge among South Africans Aged 24 to 40 Years Old. <italic>Journal</italic><italic>of</italic><italic>Human</italic><italic>Hypertension</italic>, 39, 177-187. https://doi.org/10.1038/s41371-024-00957-8 <pub-id pub-id-type="doi">10.1038/s41371-024-00957-8</pub-id><pub-id pub-id-type="pmid">39994423</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1038/s41371-024-00957-8">https://doi.org/10.1038/s41371-024-00957-8</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Mtintsilana, A.</string-name>
              <string-name>Mapanga, W.</string-name>
              <string-name>Craig, A.</string-name>
              <string-name>Dlamini, S.N.</string-name>
              <string-name>Norris, S.A.</string-name>
              <string-name>Prevalence, R</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Self-Reported Hypertension Prevalence, Risk Factors, and Knowledge among South Africans Aged 24 to 40 Years Old</article-title>
            <source>Journal of Human Hypertension</source>
            <volume>39</volume>
            <pub-id pub-id-type="doi">10.1038/s41371-024-00957-8</pub-id>
            <pub-id pub-id-type="pmid">39994423</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Ayo Bivigou, E., Moutombi Ditombi, B., Mbang Nguema, O., Moutongo, R., Pongui, B., Ekomi, B., <italic>et al</italic>. (2022) Hypertension: Prevalence and Associated Factors in Gabonese Youth and Adolescents. <italic>Cardiology</italic><italic>and</italic><italic>Cardiovascular</italic><italic>Research</italic>, 6, 32-38. https://doi.org/10.11648/j.ccr.20220601.15 <pub-id pub-id-type="doi">10.11648/j.ccr.20220601.15</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11648/j.ccr.20220601.15">https://doi.org/10.11648/j.ccr.20220601.15</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Bivigou, E.</string-name>
              <string-name>Ditombi, B.</string-name>
              <string-name>Nguema, O.</string-name>
              <string-name>Moutongo, R.</string-name>
              <string-name>Pongui, B.</string-name>
              <string-name>Ekomi, B.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Hypertension: Prevalence and Associated Factors in Gabonese Youth and Adolescents</article-title>
            <source>Cardiology and Cardiovascular Research</source>
            <volume>6</volume>
            <pub-id pub-id-type="doi">10.11648/j.ccr.20220601.15</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Kuissi Kamgaing, E., Allognon, M.C., Minto’o, S., Mboungou Ikouanga, R., Koumba Maniaga, R., Mintsa Mi NKama, E., <italic>et al</italic>. (2022) Aspects epidémiologiques et facteurs associés à l’hypertension artérielle de l’enfant en milieu scolaire à li-breville en 2021. <italic>Health</italic><italic>Sciences</italic><italic>and</italic><italic>Disease</italic>, 13, 11-15.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Kamgaing, E.</string-name>
              <string-name>Allognon, M.C.</string-name>
              <string-name>Ikouanga, R.</string-name>
              <string-name>Maniaga, R.</string-name>
              <string-name>NKama, E.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Aspects epidémiologiques et facteurs associés à l’hypertension artérielle de l’enfant en milieu scolaire à li-breville en 2021</article-title>
            <source>Health Sciences and Disease</source>
            <volume>13</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Ndoume Obiang, F., Akagha Konde, C., Yekini, C., Kinga, A., Ndjibah Alakoua, L.C., Babongui, L., <italic>et al</italic>. (2026) Hypertension artérielle du sujet jeune à libreville: Une pathologie sévère et pourvoyeuse de complications rénales. <italic>Health</italic><italic>Sciences</italic><italic>and</italic><italic>Disease</italic>, 27, 99-104.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Obiang, F.</string-name>
              <string-name>Konde, C.</string-name>
              <string-name>Yekini, C.</string-name>
              <string-name>Kinga, A.</string-name>
              <string-name>Alakoua, L.C.</string-name>
              <string-name>Babongui, L.</string-name>
            </person-group>
            <year>2026</year>
            <article-title>Hypertension artérielle du sujet jeune à libreville: Une pathologie sévère et pourvoyeuse de complications rénales</article-title>
            <source>Health Sciences and Disease</source>
            <volume>27</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., <italic>et al</italic>. (2018) 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH). <italic>European</italic><italic>Heart</italic><italic>Journal</italic>, 39, 3021-3104. https://doi.org/10.1093/eurheartj/ehy339 <pub-id pub-id-type="doi">10.1093/eurheartj/ehy339</pub-id><pub-id pub-id-type="pmid">30165516</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/eurheartj/ehy339">https://doi.org/10.1093/eurheartj/ehy339</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Williams, B.</string-name>
              <string-name>Mancia, G.</string-name>
              <string-name>Spiering, W.</string-name>
              <string-name>Rosei, E.</string-name>
              <string-name>Azizi, M.</string-name>
              <string-name>Burnier, M.</string-name>
            </person-group>
            <year>2018</year>
            <article-title>2018 ESC/ESH Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and the European Society of Hypertension (ESH)</article-title>
            <source>European Heart Journal</source>
            <volume>39</volume>
            <pub-id pub-id-type="doi">10.1093/eurheartj/ehy339</pub-id>
            <pub-id pub-id-type="pmid">30165516</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Vithalapara, P.N., Ramana, N.P., Chavada, N.M. and Babriya, D.G. (2025) Prevalence and Risk Factors of Hypertension in Young Adults: A Cross-Sectional Study. <italic>Journal</italic><italic>of</italic><italic>Heart</italic><italic>Valve</italic><italic>Disease</italic>, 30, 69-72.</mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Vithalapara, P.N.</string-name>
              <string-name>Ramana, N.P.</string-name>
              <string-name>Chavada, N.M.</string-name>
              <string-name>Babriya, D.G.</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Prevalence and Risk Factors of Hypertension in Young Adults: A Cross-Sectional Study</article-title>
            <source>Journal of Heart Valve Disease</source>
            <volume>30</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Everett, B. and Zajacova, A. (2016) Gender Differences in Hypertension and Hypertension Awareness among Young Adults. <italic>Biodemography and Social Biology</italic>, 61, 1-17. https://doi.org/10.1080/19485565.2014.929488 <pub-id pub-id-type="doi">10.1080/19485565.2014.929488</pub-id><pub-id pub-id-type="pmid">25879259</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1080/19485565.2014.929488">https://doi.org/10.1080/19485565.2014.929488</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Everett, B.</string-name>
              <string-name>Zajacova, A.</string-name>
            </person-group>
            <year>2016</year>
            <article-title>Gender Differences in Hypertension and Hypertension Awareness among Young Adults</article-title>
            <source>Biodemography and Social Biology</source>
            <volume>61</volume>
            <pub-id pub-id-type="doi">10.1080/19485565.2014.929488</pub-id>
            <pub-id pub-id-type="pmid">25879259</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Naidoo, S., Fabian, J. and Norris, S. (2023) Prevalence and Associated Risk Factors for Elevated Blood Pressure in Young Adults in South Africa. <italic>Cardiovascular</italic><italic>Journal</italic><italic>of</italic><italic>Africa</italic>, 34, 31-37. https://doi.org/10.5830/cvja-2022-036 <pub-id pub-id-type="doi">10.5830/cvja-2022-036</pub-id><pub-id pub-id-type="pmid">35976675</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.5830/cvja-2022-036">https://doi.org/10.5830/cvja-2022-036</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Naidoo, S.</string-name>
              <string-name>Fabian, J.</string-name>
              <string-name>Norris, S.</string-name>
            </person-group>
            <year>2023</year>
            <article-title>Prevalence and Associated Risk Factors for Elevated Blood Pressure in Young Adults in South Africa</article-title>
            <source>Cardiovascular Journal of Africa</source>
            <volume>34</volume>
            <pub-id pub-id-type="doi">10.5830/cvja-2022-036</pub-id>
            <pub-id pub-id-type="pmid">35976675</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Adoubi, K.A., Nguetta, R., Yangni-Angate, K.H, Diby, K.F. and Adoh, A.M. (2006) Aspects epidémiologiques, cliniques et thérapeutiques de l’hypertension artérielle à Bouake. <italic>Cahier</italic><italic>de</italic><italic>Santé</italic><italic>Publique</italic>, 5, 28-35.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Adoubi, K.A.</string-name>
              <string-name>Nguetta, R.</string-name>
              <string-name>Yangni-Angate, K.H</string-name>
              <string-name>Diby, K.F.</string-name>
              <string-name>Adoh, A.M.</string-name>
            </person-group>
            <year>2006</year>
            <article-title>Aspects epidémiologiques, cliniques et thérapeutiques de l’hypertension artérielle à Bouake</article-title>
            <source>Cahier de Santé Publique</source>
            <volume>5</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Amah, G. and Levy, B.I. (2007) Particularités de l’hypertension du sujet noir-africain. <italic>Sang</italic><italic>Thrombose</italic><italic>Vaisseaux</italic>, 19, 519-525.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Amah, G.</string-name>
              <string-name>Levy, B.I.</string-name>
            </person-group>
            <year>2007</year>
            <article-title>Particularités de l’hypertension du sujet noir-africain</article-title>
            <source>Sang Thrombose Vaisseaux</source>
            <volume>19</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Langtar, M.H., Allah-Amine, A.K., Narcisse, D., Kiram, M.D., Tamoua, N.D., Bachar, A., <italic>et al</italic>. (2024) Épidémiologie et facteurs de risque de l’hypertension artérielle persistante au décours d’une pré-éclampsie: Étude longitudinale à l’Hôpital de l’Amitié Tchad-Chine. <italic>The</italic><italic>Pan</italic><italic>African</italic><italic>Medical</italic><italic>Journal</italic>, 49, Article No. 44. https://doi.org/10.11604/pamj.2024.49.44.43783 <pub-id pub-id-type="doi">10.11604/pamj.2024.49.44.43783</pub-id><pub-id pub-id-type="pmid">39867549</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11604/pamj.2024.49.44.43783">https://doi.org/10.11604/pamj.2024.49.44.43783</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Langtar, M.H.</string-name>
              <string-name>Allah-Amine, A.K.</string-name>
              <string-name>Narcisse, D.</string-name>
              <string-name>Kiram, M.D.</string-name>
              <string-name>Tamoua, N.D.</string-name>
              <string-name>Bachar, A.</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Épidémiologie et facteurs de risque de l’hypertension artérielle persistante au décours d’une pré-éclampsie: Étude longitudinale à l’Hôpital de l’Amitié Tchad-Chine</article-title>
            <source>The Pan African Medical Journal</source>
            <volume>49</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.11604/pamj.2024.49.44.43783</pub-id>
            <pub-id pub-id-type="pmid">39867549</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Voskamp, L.W., Rousian, M., Koerts, J.J., Steegers-Theunissen, R.P.M., Danser, A.H.J. and Verdonk, K. (2025) Risk Factors for Chronic Hypertension 5 Years after a Pregnancy Complicated by Preeclampsia: A Systematic Review and Meta-Analysis. <italic>Journal</italic><italic>of</italic><italic>Hypertension</italic>, 43, 939-948. https://doi.org/10.1097/hjh.0000000000003995 <pub-id pub-id-type="doi">10.1097/hjh.0000000000003995</pub-id><pub-id pub-id-type="pmid">40079836</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1097/hjh.0000000000003995">https://doi.org/10.1097/hjh.0000000000003995</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Voskamp, L.W.</string-name>
              <string-name>Rousian, M.</string-name>
              <string-name>Koerts, J.J.</string-name>
              <string-name>Steegers-Theunissen, R.P.M.</string-name>
              <string-name>Danser, A.H.J.</string-name>
              <string-name>Verdonk, K.</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Risk Factors for Chronic Hypertension 5 Years after a Pregnancy Complicated by Preeclampsia: A Systematic Review and Meta-Analysis</article-title>
            <source>Journal of Hypertension</source>
            <volume>43</volume>
            <pub-id pub-id-type="doi">10.1097/hjh.0000000000003995</pub-id>
            <pub-id pub-id-type="pmid">40079836</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">McDonald, S.D., Malinowski, A., Zhou, Q., Yusuf, S. and Devereaux, P.J. (2008) Cardiovascular Sequelae of Preeclampsia/Eclampsia: A Systematic Review and Meta-Analyses. <italic>American</italic><italic>Heart</italic><italic>Journal</italic>, 156, 918-930. https://doi.org/10.1016/j.ahj.2008.06.042 <pub-id pub-id-type="doi">10.1016/j.ahj.2008.06.042</pub-id><pub-id pub-id-type="pmid">19061708</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.ahj.2008.06.042">https://doi.org/10.1016/j.ahj.2008.06.042</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>McDonald, S.D.</string-name>
              <string-name>Malinowski, A.</string-name>
              <string-name>Zhou, Q.</string-name>
              <string-name>Yusuf, S.</string-name>
              <string-name>Devereaux, P.J.</string-name>
            </person-group>
            <year>2008</year>
            <article-title>Cardiovascular Sequelae of Preeclampsia/Eclampsia: A Systematic Review and Meta-Analyses</article-title>
            <source>American Heart Journal</source>
            <volume>156</volume>
            <pub-id pub-id-type="doi">10.1016/j.ahj.2008.06.042</pub-id>
            <pub-id pub-id-type="pmid">19061708</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Amougou, S.N., Mbita, S.M.M., Danwe, D. and Tebeu, P. (2019) Factor Associated with Progression to Chronic Arterial Hypertension in Women with Preeclampsia in Yaoundé, Cameroon. <italic>Pan</italic><italic>African</italic><italic>Medical</italic><italic>Journal</italic>, 33, Article No. 200. https://doi.org/10.11604/pamj.2019.33.200.16857 <pub-id pub-id-type="doi">10.11604/pamj.2019.33.200.16857</pub-id><pub-id pub-id-type="pmid">31692749</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.11604/pamj.2019.33.200.16857">https://doi.org/10.11604/pamj.2019.33.200.16857</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Amougou, S.N.</string-name>
              <string-name>Mbita, S.M.M.</string-name>
              <string-name>Danwe, D.</string-name>
              <string-name>Tebeu, P.</string-name>
            </person-group>
            <year>2019</year>
            <article-title>Factor Associated with Progression to Chronic Arterial Hypertension in Women with Preeclampsia in Yaoundé, Cameroon</article-title>
            <source>Pan African Medical Journal</source>
            <volume>33</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.11604/pamj.2019.33.200.16857</pub-id>
            <pub-id pub-id-type="pmid">31692749</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Charadan, A.M.S., Boamah, K.O. and Hernandez, S. (2025) Prevalence, Risk Factors, and Outcomes of Pregnancy-Induced Hypertension at Tamale Teaching Hospital, Northern Region. <italic>Open Access Library Journal</italic>, 12, e13362. https://doi.org/10.4236/oalib.1113362 <pub-id pub-id-type="doi">10.4236/oalib.1113362</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4236/oalib.1113362">https://doi.org/10.4236/oalib.1113362</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Charadan, A.M.S.</string-name>
              <string-name>Boamah, K.O.</string-name>
              <string-name>Hernandez, S.</string-name>
              <string-name>Prevalence, R</string-name>
              <string-name>Hospital, N</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Prevalence, Risk Factors, and Outcomes of Pregnancy-Induced Hypertension at Tamale Teaching Hospital, Northern Region</article-title>
            <source>Open Access Library Journal</source>
            <volume>12</volume>
            <pub-id pub-id-type="doi">10.4236/oalib.1113362</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
    </ref-list>
  </back>
</article>